{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:01:25Z","timestamp":1792695685443,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM116119"],"award-info":[{"award-number":["GM116119"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM116119"],"award-info":[{"award-number":["GM116119"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The \u03b1<jats:sub>2<\/jats:sub> adrenergic receptor agonist dexmedetomidine is an important intravenous sedative with analgesic properties. Currently available dexmedetomidine reversal agents, like the \u03b1<jats:sub>2<\/jats:sub>-receptor antagonist atipamezole, cause serious adverse effects at the large dosages required for effective reversal; they are not used clinically. Without reversal agents, emergence times from dexmedetomidine sedation are slow. In this study we tested the ability of low-dose atipamezole, in combination with caffeine, to reverse dexmedetomidine sedation. The low dose of atipamezole employed should not be associated with unwanted effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Two different sedation protocols were employed. In the first protocol, a bolus of dexmedetomidine was rapidly applied and the drug was allowed to equilibrate for 10\u00a0min before rats received either saline (as control) or low-dose atipamezole with caffeine. Following this procedure, rats were placed on their backs. Emergence from sedation was the time for rats to recover their righting reflex and stand with 4 paws on the floor. A second sedation protocol simulated a pediatric magnetic resonance imaging (MRI) scan. Adult rats were sedated with dexmedetomidine for one hour followed by 30\u00a0min with both dexmedetomidine and propofol. At the end of 90\u00a0min, rats received either saline (control) or a combination of low-dose atipamezole, and caffeine. Recovery of the righting reflex was used as a proxy for emergence from sedation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Emergence from sedation, the time for rats to recover their righting reflex, decreased by\u2009~\u200990% when using an atipamezole dose\u2009~\u200920 fold lower than manufacturer\u2019s recommendation, supplemented with caffeine. Using an atipamezole dose\u2009~\u2009tenfold lower than recommended, with caffeine, emergence times decreased by\u2009~\u200997%. A different stimulant, forskolin, when tested, was as effective as caffeine. For the MRI simulation, emergence times were decreased by\u2009~\u200993% by low-dose atipamezole with caffeine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Low dose atipamezole with caffeine was effective at reversing dexmedetomidine sedation. Emergence was rapid and the rats regained not only their righting reflex but also their balance and their ability to carry out complex behaviors. These findings suggest that the combination of low dose atipamezole with caffeine may permit rapid clinical reversal of dexmedetomidine without unwanted effects.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12871-023-01986-5","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T05:08:54Z","timestamp":1675228134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rapid emergence from dexmedetomidine sedation in Sprague Dawley rats by repurposing an \u03b12-adrenergic receptor competitive antagonist in combination with caffeine"],"prefix":"10.1186","volume":"23","author":[{"given":"Zheng","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron P.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"1986_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jocn.2004.06.008","volume":"12","author":"JR Cormack","year":"2005","unstructured":"Cormack JR, Orme RM, Costello TG. The role of \u03b12-agonists in neurosurgery. J Clin Neurosci. 2005;12:375\u20138.","journal-title":"J Clin Neurosci"},{"key":"1986_CR2","doi-asserted-by":"publisher","first-page":"e82913","DOI":"10.1371\/journal.pone.0082913","volume":"8","author":"L Pasin","year":"2013","unstructured":"Pasin L, Greco T, Feltracco P, Vittorio A, Neto CN, Cabrini L, et al. Dexmedetomidine as a sedative agent in critically ill patients: a meta-analysis of randomized controlled trials. PLoS ONE. 2013;8:e82913.","journal-title":"PLoS ONE"},{"key":"1986_CR3","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1213\/ANE.0b013e31822b8629","volume":"113","author":"KP Mason","year":"2011","unstructured":"Mason KP, Lerman J. Dexmedetomidine in children: current knowledge and future applications. Anesth Analg. 2011;113:1129\u201342.","journal-title":"Anesth Analg"},{"key":"1986_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41589-020-0492-2","volume":"16","author":"D Yuan","year":"2020","unstructured":"Yuan D, Liu Z, Kaindl J, Maeda S, Zhao J, Sun X, et al. Activation of the \u03b12B adrenoceptor by the sedative sympatholytic dexmedetomidine. Nat Chem Biol. 2020;16:507\u201312.","journal-title":"Nat Chem Biol"},{"key":"1986_CR5","doi-asserted-by":"publisher","first-page":"174480691876364","DOI":"10.1177\/1744806918763646","volume":"14","author":"Y Yudin","year":"2018","unstructured":"Yudin Y, Rohacs T. Inhibitory Gi\/O-coupled receptors in somatosensory neurons: potential therapeutic targets for novel analgesics. Mol Pain. 2018;14:1744806918763646.","journal-title":"Mol Pain"},{"key":"1986_CR6","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1523\/JNEUROSCI.23-03-00876.2003","volume":"23","author":"V Jevtovic-Todorovic","year":"2003","unstructured":"Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, et al. Early Exposure to Common Anesthetic Agents Causes Widespread Neurodegeneration in the Developing Rat Brain and Persistent Learning Deficits. J Neurosci. 2003;23:876\u201382.","journal-title":"J Neurosci"},{"key":"1986_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ntt.2016.12.004","volume":"60","author":"CN Zanghi","year":"2017","unstructured":"Zanghi CN, Jevtovic-Todorovic V. A holistic approach to anesthesia-induced neurotoxicity and its implications for future mechanistic studies. Neurotoxicol Teratol. 2017;60:24\u201332.","journal-title":"Neurotoxicol Teratol"},{"key":"1986_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/ACO.0000000000000488","volume":"30","author":"CE Sottas","year":"2017","unstructured":"Sottas CE, Anderson BJ. Dexmedetomidine: the new all-in-one drug in paediatric anaesthesia? Curr Opin Anesthesiol. 2017;30:441\u201351.","journal-title":"Curr Opin Anesthesiol"},{"key":"1986_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/ALN.0000000000002729","volume":"131","author":"LA Daiello","year":"2019","unstructured":"Daiello LA, Racine AM, Yun Gou R, Marcantonio ER, Xie Z, Kunze LJ, et al. Postoperative Delirium and Postoperative Cognitive Dysfunction: Overlap and Divergence. Anesthesiol. 2019;131:477\u201391.","journal-title":"Anesthesiol"},{"key":"1986_CR10","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1002\/bjs.11354","volume":"107","author":"C-J Li","year":"2020","unstructured":"Li C-J, Wang B-J, Mu D-L, Hu J, Guo C, Li X-Y, et al. Randomized clinical trial of intraoperative dexmedetomidine to prevent delirium in the elderly undergoing major non-cardiac surgery. Br J Surg. 2020;107:e123\u201332.","journal-title":"Br J Surg"},{"key":"1986_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/00000542-199305000-00002","volume":"78","author":"JB Dyck","year":"1993","unstructured":"Dyck JB, Maze M, Haack C, Vuorilehto L, Shafer SL. The Pharmacokinetics and Hemodynamic Effects of Intravenous and Intramuscular Dexmedetomidine Hydrochloride in Adult Human Volunteers. Anesthesiol. 1993;78:813\u201320.","journal-title":"Anesthesiol"},{"key":"1986_CR12","first-page":"190","volume":"297","author":"R Virtanen","year":"1989","unstructured":"Virtanen R, Savola JM, Saano V. Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole. Arch Int Pharmacodyn Ther. 1989;297:190\u2013204.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"1986_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-2125.1990.tb03748.x","volume":"30","author":"S Karhuvaara","year":"1990","unstructured":"Karhuvaara S, Kallio A, Scheinin M, Anttila M, Salonen JS, Scheinin H. Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist-a randomized, double-blind cross-over study in healthy male volunteers. Br J Clin Pharmacol. 1990;30:97\u2013106.","journal-title":"Br J Clin Pharmacol"},{"key":"1986_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1365-2885.1990.tb00769.x","volume":"13","author":"AT V\u00e4h\u00e4-Vahe","year":"1990","unstructured":"V\u00e4h\u00e4-Vahe AT. The clinical effectiveness of atipamezole as a medetomidine antagonist in the dog. J Vet Pharmacol Ther. 1990;13:198\u2013205.","journal-title":"J Vet Pharmacol Ther"},{"key":"1986_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1527-3458.2005.tb00047.x","volume":"11","author":"A Pertovaara","year":"2006","unstructured":"Pertovaara A, Haapalinna A, Sirvi\u00f6 J, Virtanen R. Pharmacological Properties, Central Nervous System Effects, and Potential Therapeutic Applications of Atipamezole, a Selective \u03b12-Adrenoceptor Antagonist. CNS Drug Rev. 2006;11:273\u201388.","journal-title":"CNS Drug Rev"},{"key":"1986_CR16","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/00000542-199809000-00005","volume":"89","author":"H Scheinin","year":"1998","unstructured":"Scheinin H, Aantaa R, Anttila M, Hakola P, Helminen A, Karhuvaara S. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers. Anesthesiol. 1998;89:574\u201384.","journal-title":"Anesthesiol"},{"key":"1986_CR17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/0952-8180(93)90014-6","volume":"5","author":"M Aho","year":"1993","unstructured":"Aho M, Erkola O, Kallio A, Scheinin H, Korttila K. Comparison of dexmedetomidine and midazolam sedation and antagonism of dexmedetomidine with atipamezole. J Clin Anesth. 1993;5:194\u2013203.","journal-title":"J Clin Anesth"},{"key":"1986_CR18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1365-2125.1991.tb05505.x","volume":"31","author":"S Karhuvaara","year":"1991","unstructured":"Karhuvaara S, Kallio A, Salonen M, Tuominen J, Scheinin\u2019 M. Rapid reversal of alpha2-adrenoceptor agonist effects by atipamezole in human volunteers. Br J Clin Pharmacol. 1991;31:160\u20135.","journal-title":"Br J Clin Pharmacol."},{"key":"1986_CR19","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JAD-2010-1379","volume":"20","author":"JA Ribeiro","year":"2010","unstructured":"Ribeiro JA, Sebasti\u00e3o AM. Caffeine and Adenosine. J Alzheimer\u2019s Dis. 2010;20:S3-15.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1986_CR20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0165-6147(89)80008-2","volume":"10","author":"A Laurenza","year":"1989","unstructured":"Laurenza A, Sutkowski EM, Seamon KB. Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action? Trends Pharmacol Sci. 1989;10:442\u20137.","journal-title":"Trends Pharmacol Sci"},{"key":"1986_CR21","unstructured":"Rang HP, Dale M, Ritter J, Flower R. Rang & Dale\u2019s Pharmacology E-Book - 6th edn. 2007. https:\/\/www.elsevier.com\/books\/rang-and-dales-pharmacology-e-book\/rang\/978-0-7020-4074-0. Accessed 7 Sep 2020."},{"key":"1986_CR22","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/ani10061050","volume":"10","author":"LT Kint","year":"2020","unstructured":"Kint LT, Seewoo BJ, Hyndman TH, Clarke MW, Edwards SH, Rodger J, et al. The Pharmacokinetics of Medetomidine Administered Subcutaneously during Isoflurane Anaesthesia in Sprague-Dawley Rats. Anim. 2020;10:1050.","journal-title":"Anim"},{"key":"1986_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1460-9592.2008.02468.x","volume":"18","author":"KP Mason","year":"2008","unstructured":"Mason KP, Zurakowski D, Zgleszewski SE, Robson CD, Carrier M, Hickey PR, et al. High dose dexmedetomidine as the sole sedative for pediatric MRI. Pediatr Anesth. 2008;18:403\u201311.","journal-title":"Pediatr Anesth"},{"key":"1986_CR24","unstructured":"Pfizer. A phase 3\/4 randomized, double-blind, dose-ranging study of the safety and efficacy of dexmedetomidine (dex) used with propofol (pro) as needed for procedural sedation of pediatric subjects \u22651month to <17 years of age undergoing MRI scans. Clinical trial registration. clinicaltrials.gov; 2021."},{"key":"1986_CR25","doi-asserted-by":"publisher","first-page":"e0241818","DOI":"10.1371\/journal.pone.0241818","volume":"15","author":"AP Fox","year":"2020","unstructured":"Fox AP, Wagner KR, Towle VL, Xie KG, Xie Z. Caffeine reverses the unconsciousness produced by light anesthesia in the continued presence of isoflurane in rats. PLoS One. 2020;15:e0241818.","journal-title":"PLoS One."},{"key":"1986_CR26","first-page":"113","volume":"16","author":"E Dewhirst","year":"2011","unstructured":"Dewhirst E, Naguib A, Tobias JD. Dexmedetomidine as Part of Balanced Anesthesia Care in Children With Malignant Hyperthermia Risk and Egg Allergy. J Pediatr Pharmacol Ther. 2011;16:113\u20137.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"1986_CR27","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/ALN.0b013e31819daedd","volume":"110","author":"RD Sanders","year":"2009","unstructured":"Sanders RD, Xu J, Shu Y, Januszewski A, Halder S, Fidalgo A, et al. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiol. 2009;110:1077\u201385.","journal-title":"Anesthesiol"},{"key":"1986_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000475928","volume":"43","author":"DB Andropoulos","year":"2018","unstructured":"Andropoulos DB. Effect of Anesthesia on the Developing Brain: Infant and Fetus. Fetal Diagn Ther. 2018;43:1\u201311.","journal-title":"Fetal Diagn Ther"},{"issue":"Pt 1","key":"1986_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1042\/bj2920283","volume":"292","author":"A Remaury","year":"1993","unstructured":"Remaury A, Larrouy D, Daviaud D, Rouot B, Paris H. Coupling of the alpha 2-adrenergic receptor to the inhibitory G-protein Gi and adenylate cyclase in HT29 cells. Biochem J. 1993;292(Pt 1):283\u20138.","journal-title":"Biochem J"},{"key":"1986_CR30","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1523\/JNEUROSCI.4899-04.2005","volume":"25","author":"CL Marker","year":"2005","unstructured":"Marker CL. Spinal G-Protein-Gated Potassium Channels Contribute in a Dose-Dependent Manner to the Analgesic Effect of - and - But Not -Opioids. J Neurosci. 2005;25:3551\u20139.","journal-title":"J Neurosci"},{"key":"1986_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1098\/rspb.1991.0061","volume":"244","author":"E Seward","year":"1991","unstructured":"Seward E, Hammond C, Henderson G, Cuthbert AW. \u03bc-Opioid-receptor-mediated inhibidon of the N-type calcium-channel current. Proc R Soc Lond B. 1991;244:129\u201335.","journal-title":"Proc R Soc Lond B"},{"key":"1986_CR32","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1152\/jn.00792.2013","volume":"111","author":"Q Wang","year":"2014","unstructured":"Wang Q, Fong R, Mason P, Fox AP, Xie Z. Caffeine accelerates recovery from general anesthesia. J Neurophysiol. 2014;111:1331\u201340.","journal-title":"J Neurophysiol"},{"key":"1986_CR33","first-page":"912","volume":"129","author":"R Fong","year":"2018","unstructured":"Fong R, Wang L, Zacny JP, Khokhar S, Apfelbaum JL, Fox AP, et al. Caffeine Accelerates Emergence from Isoflurane Anesthesia in Humans: A Randomized, Double-blind. Crossover Study Anesthesiol. 2018;129:912\u201320.","journal-title":"Crossover Study Anesthesiol"},{"key":"1986_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0165-6147(99)01307-3","volume":"20","author":"WF Simonds","year":"1999","unstructured":"Simonds WF. G protein regulation of adenylate cyclase. Trends Pharmacol Sci. 1999;20:66\u201373.","journal-title":"Trends Pharmacol Sci"},{"key":"1986_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/ALN.0b013e318278c896","volume":"118","author":"NE Taylor","year":"2013","unstructured":"Taylor NE, Chemali JJ, Brown EN, Solt K. Activation of D1 Dopamine Receptors Induces Emergence from Isoflurane General Anesthesia. Anesthesiol. 2013;118:30\u20139.","journal-title":"Anesthesiol"},{"key":"1986_CR36","doi-asserted-by":"publisher","first-page":"668285","DOI":"10.3389\/fphar.2021.668285","volume":"12","author":"R Kato","year":"2021","unstructured":"Kato R, Zhang ER, Mallari OG, Moody OA, Vincent KF, Melonakos ED, et al. D-Amphetamine Rapidly Reverses Dexmedetomidine-Induced Unconsciousness in Rats. Front Pharmacol. 2021;12:668285.","journal-title":"Front Pharmacol"},{"issue":"Suppl 3","key":"1986_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3109\/14767058.2010.517704","volume":"23","author":"JV Aranda","year":"2010","unstructured":"Aranda JV, Beharry K, Valencia GB, Natarajan G, Davis J. Caffeine impact on neonatal morbidities. J Matern Fetal Neonatal Med. 2010;23(Suppl 3):20\u20133.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1986_CR38","doi-asserted-by":"publisher","first-page":"110284","DOI":"10.1016\/j.jclinane.2021.110284","volume":"72","author":"H Ma","year":"2021","unstructured":"Ma H, Wachtendorf LJ, Santer P, Schaefer MS, Friedrich S, Nabel S, et al. The effect of intraoperative dexmedetomidine administration on length of stay in the post-anesthesia care unit in ambulatory surgery: A hospital registry study. J Clin Anesth. 2021;72:110284.","journal-title":"J Clin Anesth"},{"key":"1986_CR39","volume-title":"Review of the Fialuridine (FIAU) clinical trials","author":"Institute of Medicine (US) Committee to Review the Fialuridine (FIAU\/FIAC) Clinical Trials","year":"1995","unstructured":"Institute of Medicine (US) Committee to Review the Fialuridine (FIAU\/FIAC) Clinical Trials. Review of the Fialuridine (FIAU) clinical trials. Washington (DC): National Academies Press (US); 1995."},{"key":"1986_CR40","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1177\/1098612X17722265","volume":"20","author":"M Martin-Flores","year":"2018","unstructured":"Martin-Flores M, Sakai DM, Honkavaara J, Campoy L. Hemodynamic effects of low-dose atipamezole in isoflurane-anesthetized cats receiving an infusion of dexmedetomidine. J Feline Med Surg. 2018;20:571\u20137.","journal-title":"J Feline Med Surg"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-023-01986-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-023-01986-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-023-01986-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T05:09:25Z","timestamp":1675228165000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-023-01986-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1986"],"URL":"https:\/\/doi.org\/10.1186\/s12871-023-01986-5","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"22 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human subjects: N\/A.Animal studies: This study on rats was approved by The University of Chicago Institutional Animal Care and Use Committees (IACUCs) with protocol #42437. In between experiments animals were cared for by University of Chicago veterinary staff. All experiments were performed in accordance with relevant guidelines and regulations.All methods are reported in accordance with ARRIVE guidelines () for the reporting of animal experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No conflict of interest, financial or otherwise are declared by the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}